Flamel Technologies SA (NASDAQ:FLML)

Data as of Jan 30
 -0.20 / -1.37%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Flamel Technologies SA engages in the development, manufacture, and marketing of pharmaceutical products. It operates under the following trademarks: Flamel Technologies, Bloxiverz, Micropump, LiquiTime, Trigger Lock, Medusa, DeliVax, and Vazculep. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France.

Contact Information

Flamel Technologies SA
33, avenue du Dr. Georges Lévy
Vénissieux Rhone-alpes 69200
P:(347) 278-3434
Investor Relations:



Other institutional44.30%
Mutual fund holders19.46%
Individual stakeholders--

Top Executives

Michael Shannon AndersonChief Executive Officer & Director
Rafael JordaChief Operating Officer & Executive Vice President
Siân CrouzetChief Financial Officer
Christian KalitaChief Pharmacist, Director-Quality & Regulatory
Phillandas T. ThompsonSenior Vice President & General Counsel

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.